The fund normally invests at least 80% of its assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment, devices, and related technologies, companies enabling drug discovery, and companies providing information technology services primarily to health care providers. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. The fund is non-diversified.